The OTC Markets Group has launched its own cannabis index designed to track the performance of the 30 leading marijuana firms trading on its market.

It has 56 cannabis-related securities trading on its OTCQX Best Market and it revealed that the top 30 account for more than 25% of total year-to-date volume in OTCQX Market securities. Members of the new index include The Green Organic Dutchman, Organigram, iAnthus, and Cresco Labs.

“The exponential growth in publicly-traded cannabis securities underscores the willingness of these companies to provide efficient trading and enhanced disclosure for investors,” said Jason Paltrowitz, executive vice president of Corporate Services at OTC Markets Group.

The aim of the index is to allow investors to identify, measure and track the performance of the cannabis industry as it progresses. There are notable absentees, as the likes of Canopy, Aurora, Aphria, and Tilray are not included. Yet it could prove to be an interesting measure of how the next tier of companies in this dynamic industry is faring.

It features several large, vertically integrated cannabis companies from across the U.S. and America. AusCann, Aleafia, Beleave, Auxly, Cannex, Curaleaf, Charlotte’s Web, Elixinol, Emerald Health Therapeutics, Harvest One, Harvest Health & Recreation, InMed, Invictus MD, James E Wagner Cultivation, Lifestyle Delivery Systems, MedMen, Indiva, CannaRoyalty, Supreme Cannabis, THC BioMed, True Leaf, Terra Tech, Vivo and WeedMD are all featured.

The base date is Apr. 1, 2019, and the base index level is 1,000. It can be found under OTCQXMJ and it opened at 743.31 today. Securities must adhere to the financial, disclosure and corporate governance standards laid down by the group if they are to trade on the OTCQX Best Market.

Investors can already refer to the Horizons Marijuana Life Sciences index or the ETFMG Alternative Harvest exchange-traded fund MJ when seeking an overview on how the sector is performing. Both saw gains today ending a five-day streak in which they consistently decreased.

The gains came as the S&P 500 index and the Dow Jones Industrial Average rallied. Yesterday, Deloitte had positive news for the Canadian industry as it estimated the next round of legalization will see the market grow by $2.5 billion a year as demand for edibles and beverages is expected to soar.

About Author

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.